Towards Safer Medication Use in Older Adults: Investigating Barriers and Facilitators to Deprescribing
Madhavi Eerike, Gomathi Ramaswamy, Priyadharsini Rajendran, Paul Mathai, Veena Nayak, Vijay Kumar Karra

TL;DR
This study explores challenges and solutions for safely reducing unnecessary medications in older adults through healthcare professionals' perspectives.
Contribution
The study provides new qualitative insights into barriers and facilitators of deprescribing from healthcare professionals' viewpoints.
Findings
Barriers include limited healthcare access, knowledge gaps, and systemic inefficiencies.
Facilitators include patient involvement, EHR integration, and improved interdisciplinary collaboration.
Chronic use of PPIs and benzodiazepines poses significant obstacles to deprescribing.
Abstract
Deprescribing, the systematic reduction or discontinuation of unnecessary medications, is crucial for optimizing pharmacotherapy in older adults. However, its implementation faces challenges, including systemic barriers, knowledge gaps, and patient-specific complexities. Understanding healthcare professionals’ perspectives is vital to improving deprescribing practices and enhancing elderly patients’ health outcomes. This qualitative study employed in-depth interviews with healthcare professionals (n = 52) to explore barriers, facilitators, and potential improvements in deprescribing. Thematic analysis was used to identify key insights and patterns from the collected data. Key barriers included limited access to healthcare services, particularly in rural and underserved areas, and knowledge gaps in geriatric pharmacology among resident doctors. Patient-specific challenges, such as…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Practices and Patient Outcomes · Medication Adherence and Compliance · Pharmacovigilance and Adverse Drug Reactions
